Skip to content
  • Preclinical Services
    • In vivo Models
    • Ex vivo Models for advanced research
    • In vitro Models
    • Image Analysis / Advanced preclinical imaging solutions
    • R&D
  • Applications
    • Drug disposition / PK
    • Dermatology
      • Atopic Dermatitis Models
        • Oxazolone Atopic Dermatitis Model
        • IL-23 Atopic Dermatitis Model
        • Itching Skin Models
      • Acne Models
        • Cutibacterium acnes (C. acnes) Acne Model
        • Rhino Mouse Acne Model
        • Hamster Flank Organ Acne Model
      • Psoriasis Mouse Models
        • Imiquimod IMQ Psoriasis Model
        • IL-23 Psoriasis Mouse Model
      • Wound Healing Models
        • Ischemic Wound Healing Models
      • Alopecia preclinical models
      • Rosacea Model
      • Imaging of Dermatology Models
    • Oncology models
    • Osteo-Articular Pathologies
      • Psoriatic Arthritis Model
      • Rheumatoid Arthritis Model
      • Ankylosing Spondylitis Model
      • Bone Healing & Osteoporosis Model
    • Infectious diseases
    • Neurology
    • Cardiovascular
      • Atherosclerosis Models
      • Myocardial Infarction Model
    • Medical Devices
  • Who we are
  • News
  • Preclinical Services
    • In vivo Models
    • Ex vivo Models for advanced research
    • In vitro Models
    • Image Analysis / Advanced preclinical imaging solutions
    • R&D
  • Applications
    • Drug disposition / PK
    • Dermatology
      • Atopic Dermatitis Models
        • Oxazolone Atopic Dermatitis Model
        • IL-23 Atopic Dermatitis Model
        • Itching Skin Models
      • Acne Models
        • Cutibacterium acnes (C. acnes) Acne Model
        • Rhino Mouse Acne Model
        • Hamster Flank Organ Acne Model
      • Psoriasis Mouse Models
        • Imiquimod IMQ Psoriasis Model
        • IL-23 Psoriasis Mouse Model
      • Wound Healing Models
        • Ischemic Wound Healing Models
      • Alopecia preclinical models
      • Rosacea Model
      • Imaging of Dermatology Models
    • Oncology models
    • Osteo-Articular Pathologies
      • Psoriatic Arthritis Model
      • Rheumatoid Arthritis Model
      • Ankylosing Spondylitis Model
      • Bone Healing & Osteoporosis Model
    • Infectious diseases
    • Neurology
    • Cardiovascular
      • Atherosclerosis Models
      • Myocardial Infarction Model
    • Medical Devices
  • Who we are
  • News
Contact Us

Past Events

  • AFSTAL 2019 / October 2-4th 2019 / La Rochelle, France
    A poster was presented on innovating approach of skin imaging with results and application of Optical Coherence Tomography (OCT) in dermatology models
  • 14th FELASA congress 2019 – Prague / Czech Republic – June 10th to 13th 2019
  • Toulouse OncoWeek 2018 / TOW2018 – Toulouse / France – February 3rd to 7th 2018
  • Biofit 2017 – Strasbourg / France – November 28th & 29th 2017
  • Toulouse OncoWeek 2016 / TOW2016 – Toulouse / France – February 3rd to 5th 2016
  • FELASA 2016 congress – Brussels / Belgium – 13-16 June, 2016
  • Biofit 2016 – Lille / France – 2 to 3 December 2016
  • Biofit 2015 – Strasbourg / France – 2 to 3 December 2015
  • Formation Cancéropôle Grand Sud Ouest – Développement d’un médicament : de la biologie à la recherche clinique / Montpellier – 2-3 octobre 2015
  • Workshop Cancer & Technologies pour la Santé / Cancéropôle Grand Sud Ouest / Hôpital Purpan Toulouse / France – 17-18 septembre 2015
  • Bionetwork Meeting / Pôle Cancer-Bio-Santé / Toulouse Metropole / September 10th 2015
  • BioFIT 2014, December 2&3th 2014, Lille, France
  • European Cancer Cluster Partnering, 14-15 october 2013, Toulouse, France (BtoB meetings)
  • Imagerie Medicale B4B-Connection, 2-3 october 2013, Bordeaux, France (Business presentation, BtoB meetings)
  • Outsourcing Drug Development ODD, 18 september 2013, Evreux, France
  • Technology Company Congress / Congrès des Entreprises Technologiques, 17 september 2013, Evreux, France
  • FELASA 2013 congress, 10-13 june 2013, Barcelona, Spain, “Animal Research: Better science from fewer animals”
  • 3rd pre-clinical imaging course, 27-30 may 2013, Montpellier, France
  • Cancer Cell Death & Resistance International Congress, 6-7 may 2013, Seilh, Toulouse region, France
  • Biomarqueurs B4B-Connection, 10-11 April 2013, Paris, France (BtoB meetings)
Imavita S.A.S
64 impasse de la Viguerie
ZA La Masquère
F-31750 Escalquens
France
+33 (0)9 72 60 18 16
Quick links:
Applications
Preclinical services
Who we are
News
Domains / Applications:
Drug disposition / PK / Biodistribution
Dermatology
Osteo-articular
Oncology
Neurology
Cardiovascular
Infectious diseases
Medical Devices / MD
Contact Us
Linkedin X-twitter Instagram Youtube

©2013-2025 Imavita S.A.S. All rights reserved. | Legal mentions.